CytoMed Therapeutics
GDTC
#10421
Rank
โ‚น1.27 B
Marketcap
โ‚น107.56
Share price
-7.38%
Change (1 day)
-46.95%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for CytoMed Therapeutics CIK: 0001873093
The 20-F is a 10-K equivalent for non-US companies, as a foreight company CytoMed Therapeutics only files 20-F reports

Thumbnail CytoMed Therapeutics 20-F Annual Report

20-F Annual Report 2026-03-31

Language: English

View Annual Report (20-F)
Thumbnail CytoMed Therapeutics 20-F Annual Report

20-F Annual Report 2025-04-28

Language: English

View Annual Report (20-F)
Thumbnail CytoMed Therapeutics 20-F Annual Report

20-F Annual Report 2024-04-22

Language: English

View Annual Report (20-F)
Thumbnail CytoMed Therapeutics 20-F Annual Report

20-F Annual Report 2023-05-01

Language: English

View Annual Report (20-F)